Literature DB >> 24220312

High fat diet causes renal fibrosis in LDLr-null mice through MAPK-NF-κB pathway mediated by Ox-LDL.

Yao Dai1, Philip Palade, Xianwei Wang, Federico Mercanti, Zufeng Ding, Dongsheng Dai, Jawahar L Mehta.   

Abstract

BACKGROUND: Dyslipidemia, particularly increased LDL-cholesterol level in serum, is associated with atherosclerosis and fibrosis in different organs. This study was designed to investigate the effects of increase in LDL-cholesterol on renal fibrosis.
METHODS: Wild-type (WT) and LDLr knockout (KO) mice were fed standard or high fat diet (HFD), and their kidneys were collected after 26 weeks of dietary intervention for identification of fibrosis and study of potential mechanisms. Additional studies were performed in cultured renal fibroblasts.
RESULTS: We observed extensive and diffuse fibrosis in the kidneys of mice given HFD (P < 0.05 vs. standard chow). Fibrosis was associated with enhanced expression of fibronectin, nicotinamide adenine dinucleotide phosphate oxidases and activated p38 and p44/42 mitogen-activated protein kinases (MAPKs) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). There was evidence for accumulation of 4-hydroxynonenal, a lipid peroxidation product, in the kidneys and of ox-LDL in the arteries of LDLr KO mice given HFD. The expression of ox-LDL receptor LOX-1 and of transforming growth factor beta 1 (TGFβ1) was increased in these kidneys. All these changes were more pronounced in LDLr KO mice than in the WT mice. In in vitro studies, treatment of fibroblasts from kidneys of LDLr KO mice with ox-LDL showed intense proliferation and collagen formation (all P < 0.05, fibroblasts from WT mice kidneys). Blockade of p38 MAPK, p44/42 MAPK, or NF-κB significantly attenuated expression of profibrotic signals, collagen formation, and proliferation of fibroblasts.
CONCLUSIONS: HFD induces renal fibrosis in LDLr-null mice primarily through activation of the nicotinamide adenine dinucleotide phosphate oxidase MAPK-NF-κB pathway by ox-LDL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24220312     DOI: 10.1097/FJC.0000000000000035

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  13 in total

Review 1.  Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.

Authors:  John N Stabley; Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-22       Impact factor: 8.311

2.  Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.

Authors:  Ahmed Bettaieb; Shinichiro Koike; Ming-Fo Hsu; Yoshihiro Ito; Samah Chahed; Santana Bachaalany; Artiom Gruzdev; Miguel Calvo-Rubio; Kin Sing Stephen Lee; Bora Inceoglu; John D Imig; Jose M Villalba; Darryl C Zeldin; Bruce D Hammock; Fawaz G Haj
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-07-27       Impact factor: 3.770

3.  Trichosanatine alleviates oxidized low-density lipoprotein induced endothelial cells injury via inhibiting the LOX-1/p38 MAPK pathway.

Authors:  Lei Zhang; Yu-Hua Jia; Xiao-Shan Zhao; Feng-Hua Zhou; Yun-Yun Pan; Qiang Wan; Xiao-Bing Cui; Xue-Gang Sun; Yu-Yao Chen; Yu Zhang; Sai-Bo Cheng
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

4.  Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats.

Authors:  Maged W Helmy; Hanan M El-Gowelli; Rabab M Ali; Mahmoud M El-Mas
Journal:  Br J Pharmacol       Date:  2015-07-30       Impact factor: 8.739

5.  Dedicator of Cytokinesis 2 (DOCK2) Deficiency Attenuates Lung Injury Associated with Chronic High-Fat and High-Fructose Diet-Induced Obesity.

Authors:  Guoqing Qian; Oluwaseun Adeyanju; Christudas Sunil; Steven K Huang; Shi-You Chen; Torry A Tucker; Steven Idell; Xia Guo
Journal:  Am J Pathol       Date:  2021-11-10       Impact factor: 4.307

6.  Blockade of Orai1 Store-Operated Calcium Entry Protects against Renal Fibrosis.

Authors:  Xiaoyi Mai; Jinyan Shang; Sijia Liang; Beixin Yu; Jiani Yuan; Yu Lin; Renfei Luo; Feiran Zhang; Yingying Liu; Xiaofei Lv; Chunling Li; Xinling Liang; Weidong Wang; Jiaguo Zhou
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

Review 7.  Diabetic fibrosis.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-12-28       Impact factor: 5.187

8.  Synergistic action of inflammation and lipid dysmetabolism on kidney damage in rats.

Authors:  Zhongjie Wang; Wenhan Huang; Hui Li; Lin Tang; Hang Sun; Qi Liu; Ling Zhang
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

Review 9.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

10.  The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice.

Authors:  Jingjing Li; Meiping Guan; Chenzhong Li; Fuping Lyv; Yanmei Zeng; Zongji Zheng; Chengzhi Wang; Yaoming Xue
Journal:  Int J Mol Sci       Date:  2014-06-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.